Endo International has appointed Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately.     In this role, Mr. Ciarico will lead commercial strategy and execution for Endo’s Generics Pharmaceutical and Sterile Injectable businesses which are marketed and sold under the Par Pharmaceutical brand. He will report to Paul Campanelli, President and Chief Executive Officer, and will join the company’s Executive Leadership Team...